Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 November 1997

Long-term effects of vaccination against hepatitis virus B infection in children with neoplastic disease

Jan Styczyński, Mariusz Wysocki, Sylwia Kołtan, Andrzej Kurylak, Anna Balcar-Boroń

Med Sci Monit 1997; 3(6): CR864-868 :: ID: 501816


The purpose of the study was to assess the durability of humoral immunity in children with neoplastic disease 2.5 years after vaccination against hepatitis B virus. The study included 53 children divided into 3 groups, according to the method of passive-active prophylaxis. In group A first came passive prophylaxis during intensive chemotherapy, followed by the vaccination during supportive treatment; in group B children were vaccinated from the very beginning of chemotherapy with simultaneous administration of 2 doses of anti-HBs immunoglobulin; in group C patients received vaccination only after the completion of chemotherapy. Engerix-B vaccine was used for vaccination, and was administered in double doses, in regimen 0-1-2-8 months. Humoral response was evaluated in the 6th and 30th month following the fourth vaccination. After the vaccination cycle was completed, seroprotection was obtained in 66.7% of children in group A, 81.3% in group B and 100% in group C. Two and a half years after the termination of vaccination, all patients with primary seroconversion still possessed anti-HBs antibodies, while in two children the anti-HBs antibodies appeared after the discontinuation of chemotherapy. Anti-HBs antibody level increased in 45.3% of patients. Among patients who received the last dose of vaccine upon the completion of chemotherapy, as compared to those who received the last dose of vaccine during chemotherapy, we found a higher percentage of seroconversion to anti-HBs³10 IU/l (p<0.01) and higher mean arithmetic (p<0.05) in the 30th month after completion of vaccination. Geometric mean value of protective level of antibodies was in these patients more than two times higher. Long-term effects of vaccination in children with neoplastic disease reveal improvement of humoral response after the discontinuation of chemotherapy. More permanent results were obtained in children who received the last dose of the vaccine upon the completion of treatment.

Keywords: HBV infection, Vaccination, antibodies maintenance, children neoplasm

Add Comment 0 Comments


01 June 2024 : Editorial  

Editorial: Concerns as Highly Pathogenic Avian Influenza (HPAI) Virus of the H5N1 Subtype is Identified in Dairy Cows and Other Mammals

Dinah V. Parums

DOI: 10.12659/MSM.945315

Med Sci Monit 2024; 30:e945315


In Press

Animal Research  

Curcumin as a Potential Therapeutic Agent for Mitigating Carbon Monoxide Poisoning: Evidence from an Experi...

Med Sci Monit In Press; DOI: 10.12659/MSM.943739  

Animal Research  

Targeting the Gut-Kidney Axis in Diarrhea with Kidney-Yang Deficiency Syndrome: The Role of Sishen Pills in...

Med Sci Monit In Press; DOI: 10.12659/MSM.944185  

Review article  

A New Pandemic of the XXIst Century: The Growing Crisis of Adolescent Depression in the Digital Age

Med Sci Monit In Press; DOI: 10.12659/MSM.944838  

Review article  

A Review of Wastewater-Based Epidemiology Studies for the Assessment of Over-the-Counter Medicines Used as ...

Med Sci Monit In Press; DOI: 10.12659/MSM.944120  

Most Viewed Current Articles

17 Jan 2024 : Review article   1,652,499

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research   1,522,350

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research   690,265

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial   50,215

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750